Skip to content
Screener

GeneDx Holdings WGS Deferred Tax Assets and Other Non-Current Assets

Deferred Tax Assets and Other Non-Current Assets at other companies

Natera, Inc. logo
Natera, Inc.NTRA
$49.99M+21.6%
Azenta logo
AzentaAZTA
$9M
Fulgent Genetics, Inc. logo
Fulgent Genetics, Inc.FLGT
Personalis, Inc. logo
Personalis, Inc.PSNL
NeoGenomics logo
NeoGenomicsNEO
Quest Diagnostics logo
Quest DiagnosticsDGX

Other financials

Income statement

See full
Revenue$102.3M+17.4%
Gross profit$68.2M+16.6%
Operating income-$57.5M-1,163%
Net income-$63.3M-870%
EPS (diluted)-$2.16-839%

Balance sheet

See full
Cash & equivalents$94.9M-5.7%
Total debt$96.7M+82.5%
Total equity$254.1M-1.3%
Total assets$506.3M+13.4%

Cash flow

See full
Operating cash flow-$32.4M-418%
CapEx$6.5M+5.3%
Free cash flow-$38.9M-1,059%

Valuation

See full
Market cap$2.32B-26.9%
Enterprise value$2.32B-26.3%
P/S5.3×-3.5×

Profitability

See full
Gross margin69.6%+4.3pp
Operating margin-14.9%
Net margin-17.6%
FCF margin3.8%+2.1pp

Returns & leverage

See full
Return on equity-30.4%
Debt / equity0.4×+0.2×
Current ratio3.1×-0.2×

Where this comes from

Reported directly by GeneDx Holdings in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The source filing: GeneDx Holdings’s 10-Q, filed May 4, 2026.

Filed
May 4, 2026, 4:15 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001818331-26-000041
Line itemMarch 31, 2026 (Unaudited)December 31, 2025
Property and equipment, net50,12545,693
Goodwill1,64113,520
Intangible assets, net144,969168,481
Other assets4,2844,316
Total assets$506,301$523,710
Liabilities and Stockholders’ Equity:
Current liabilities:
Accounts payable and accrued expenses$46,562$57,645

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is GeneDx Holdings's deferred tax assets and other non-current assets?
GeneDx Holdings (WGS) reported deferred tax assets and other non-current assets of $4.28M in Q1 2026.
How has GeneDx Holdings's deferred tax assets and other non-current assets changed year-over-year?
GeneDx Holdings's deferred tax assets and other non-current assets increased by 0.7% year-over-year, from $4.25M to $4.28M.
What is the long-term trend for GeneDx Holdings's deferred tax assets and other non-current assets?
Over 5 years (2020 to 2025), GeneDx Holdings's deferred tax assets and other non-current assets has grown at a 3.7% compound annual growth rate (CAGR), from $3.6M to $4.32M.

Ask your AI about GeneDx Holdings's deferred tax assets and other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude